𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: Clinical evaluation and cost analysis

✍ Scribed by Aletaha, Daniel ;Smolen, Josef S.

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
77 KB
Volume
47
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Medical resource use and costs among rhe
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy
✍ Griffiths, Robert I. ;Bar-Din, Miriam ;MacLean, Catherine H. ;Sullivan, Erin M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

## Objective: To identify costs among rheumatoid arthritis (ra) patients receiving alternative disease-modifying antirheumatic drug (dmard) therapies. ## Methods: Using managed care organization data, we identified members who (a) were prescribed any dmard therapy for two consecutive months betwe

Presence of significant synovitis in rhe
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression
✍ A. K. Brown; M. A. Quinn; Z. Karim; P. G. Conaghan; C. G. Peterfy; E. Hensor; R. πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract ## Objective More timely and effective therapy for rheumatoid arthritis (RA) has contributed to increasing rates of clinical remission. However, progression of structural damage may still occur in patients who have satisfied remission criteria, which suggests that there is ongoing dise